顧みられない熱帯病治療の世界市場

顧みられない熱帯病治療の世界市場は2030年までに48億米ドルに到達

2024年に38億米ドルと推定される顧みられない熱帯病治療の世界市場は、2024～2030年の分析期間においてCAGR 3.7%で成長し、2030年には48億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるNTD治療薬は、CAGR 4.6%を記録し、分析期間終了時には31億米ドルに達すると予測されます。NTDワクチン分野の成長率は、分析期間中CAGR 2.1%と推定されます。

米国市場は10億米ドルと推定、中国はCAGR 7.0％で成長予測

米国の顧みられない熱帯病治療市場は2024年に10億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR7.0％を牽引し、2030年には予測市場規模9億7,020万米ドルに達すると予測されます。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.9%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の顧みられない熱帯病治療市場- 主要動向と促進要因のまとめ

顧みられない熱帯病治療が世界の保健上の優先課題となっている理由

顧みられない熱帯病（Neglected Tropical Diseases、NTDs）は、主に低所得層や熱帯地域において、世界中で10億人以上の人々に影響を及ぼしています。リーシュマニア症、シャーガス病、住血吸虫症、デング熱を含むこれらの病気は、歴史的に他の感染症に比べて注目度も資金も限られていました。しかし、世界保健機関（WHO）、ビル&メリンダ・ゲイツ財団、各政府保健機関などの世界の意識の高まりと努力により、NTDsの治療と撲滅プログラムへの投資が推進されるようになりました。NTDsが公衆衛生上の大きな負担であるとの認識が広まったことで、医薬品流通の拡大、ワクチン開発プログラム、ベクターコントロール戦略が実施されるようになりました。さらに、製薬会社、非営利団体、政府間の協力により、費用対効果の高い治療薬の製造と流通が促進され、感染者のアクセシビリティが向上しています。公衆衛生政策がNTDの撲滅を優先するようになるにつれ、治療と予防ソリューションの市場は大きな成長が見込まれています。

NTD治療と予防における最新の進歩とは？

NTD治療の研究開発により、薬剤製剤、診断ツール、ワクチン候補の画期的な進歩がもたらされました。特にリンパ系フィラリア症や土壌伝染性蠕虫症などの疾患に対する大量薬剤投与（MDA）プログラムの採用は、流行地域における疾患の蔓延を大幅に減少させました。併用療法や長時間作用型製剤を含む新薬や再利用薬は、薬剤耐性を最小限に抑えながら治療効果を向上させています。さらに、遺伝学的・分子生物学的研究により、リーシュマニア症やデング熱などの疾患に対する次世代ワクチンの開発が促進されています。また、AIを活用した診断や遠隔モニタリングなどのデジタルヘルス技術の統合により、疾患の早期発見や治療計画が強化されています。このような技術革新により、NTD治療プログラムの有効性が向上し、より良い疾病管理、そして根絶への道が開かれつつあります。

官民パートナーシップはどのように市場拡大を促進しているのか？

NTD治療へのアクセスを拡大する上で、官民パートナーシップは重要な役割を果たしており、製薬会社は世界ヘルス組織と協力し、手頃な価格の医薬品を開発・配布しています。多くの企業が医薬品寄贈プログラムを実施し、救命治療薬をわずかな費用で、あるいは無料で被災地に提供しています。さらに、政府からの資金援助や助成金によって新規治療薬の研究が奨励され、現地のヘルスケア・インフラの改善によって治療の提供が促進されています。遠隔医療やモバイルヘルス（mヘルス）イニシアチブの台頭は、遠隔地での早期診断やタイムリーな介入を可能にし、アウトリーチをさらに向上させています。NTDsの撲滅に向けた世界の取り組みが勢いを増す中、こうしたパートナーシップによって、治療へのアクセスや疾病管理が大きく前進することが期待されます。

顧みられない熱帯病治療市場の成長を促進する主な要因は何か？

顧みられない熱帯病治療市場の成長は、世界保健資金の増加、医薬品開発の進展、官民連携の拡大など、いくつかの要因によってもたらされます。疾病撲滅プログラムへの注目の高まりは、研究、診断、ワクチン開発への多額の投資につながっています。気候変動による負担の増大は、媒介感染症の地理的広がりを拡大し、効果的な治療ソリューションの必要性をさらに高めています。さらに、デジタルヘルス技術とAI駆動型診断の統合により、流行地域における疾病監視と治療提供が改善されています。また、国民皆保険の推進と地域の医療制度の強化も、市場への浸透を促進しています。NTDs対策への世界の取り組みが持続する中、革新的で費用対効果の高い治療ソリューションの市場は拡大し、これらの疾患の撲滅に向けて大きく前進することが期待されます。

セグメント

製品タイプ（NTD治療薬、NTDワクチン）、疾患タイプ（デング熱疾患、狂犬病、トラコーマ、ブルーリ潰瘍、ヨーズ病、ハンセン病、シャーガス病、ヒトアフリカトリパノソーマ症、リーシュマニア症、土壌伝染性蠕虫病、その他の疾患タイプ）

調査対象企業の例

• Abbott Laboratories
• AbbVie Inc.
• Astellas Pharma Inc.
• AstraZeneca plc
• Bayer AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• Dr. Reddy's Laboratories Ltd.
• Eisai Co., Ltd.
• F. Hoffmann-La Roche Ltd
• Gilead Sciences, Inc.
• GlaxoSmithKline plc（GSK）
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Omega Diagnostics Group PLC
• Pfizer Inc.
• Sanofi
• Shionogi & Co., Ltd.
• Takeda Pharmaceutical Company Limited

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Neglected Tropical Disease Treatment Market to Reach US$4.8 Billion by 2030

The global market for Neglected Tropical Disease Treatment estimated at US$3.8 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. NTD Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the NTD Vaccines segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 7.0% CAGR

The Neglected Tropical Disease Treatment market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$970.2 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Neglected Tropical Disease Treatment Market - Key Trends & Drivers Summarized

Why Is Neglected Tropical Disease Treatment a Growing Global Health Priority?

Neglected Tropical Diseases (NTDs) affect over one billion people worldwide, primarily in low-income and tropical regions. These diseases, including leishmaniasis, Chagas disease, schistosomiasis, and dengue, have historically received limited attention and funding compared to other infectious diseases. However, increased global awareness and the efforts of organizations such as the World Health Organization (WHO), the Bill & Melinda Gates Foundation, and various government health agencies have propelled investment into NTD treatment and eradication programs. The growing recognition of NTDs as a major public health burden has led to expanded drug distribution initiatives, vaccine development programs, and vector control strategies. Additionally, collaborations between pharmaceutical companies, non-profit organizations, and governments have facilitated the production and distribution of cost-effective treatments, improving accessibility for affected populations. As public health policies increasingly prioritize NTD eradication, the market for treatments and preventive solutions is expected to witness significant growth.

What Are the Latest Advances in NTD Treatment and Prevention?

Research and development in NTD treatment have led to groundbreaking advancements in drug formulations, diagnostic tools, and vaccine candidates. The adoption of mass drug administration (MDA) programs, particularly for diseases such as lymphatic filariasis and soil-transmitted helminthiasis, has significantly reduced disease prevalence in endemic regions. New and repurposed drugs, including combination therapies and long-acting formulations, have improved treatment efficacy while minimizing drug resistance. Additionally, genetic and molecular research has facilitated the development of next-generation vaccines for diseases like leishmaniasis and dengue. The integration of digital health technologies, including AI-driven diagnostics and remote monitoring, has also enhanced early disease detection and treatment planning. These innovations are improving the effectiveness of NTD treatment programs, paving the way for better disease control and potential eradication.

How Are Public-Private Partnerships Driving Market Expansion?

Public-private partnerships have played a crucial role in expanding access to NTD treatments, with pharmaceutical companies collaborating with global health organizations to develop and distribute affordable medications. Many firms have implemented drug donation programs, supplying life-saving treatments to affected regions at little or no cost. Additionally, government funding and grants have incentivized research into novel therapeutics, while local healthcare infrastructure improvements have facilitated treatment delivery. The rise of telemedicine and mobile health (mHealth) initiatives has further improved outreach, enabling early diagnosis and timely intervention in remote communities. As global efforts to eliminate NTDs gain momentum, these partnerships are expected to drive significant advancements in treatment accessibility and disease management.

What Are the Key Factors Driving Growth in the Neglected Tropical Disease Treatment Market?

The growth in the neglected tropical disease treatment market is driven by several factors, including increased global health funding, advancements in drug development, and expanding public-private collaborations. The growing focus on disease eradication programs has led to significant investments in research, diagnostics, and vaccine development. The rising burden of climate change, which has expanded the geographical spread of vector-borne diseases, has further intensified the need for effective treatment solutions. Additionally, the integration of digital health technologies and AI-driven diagnostics has improved disease surveillance and treatment delivery in endemic regions. The push for universal healthcare access and the strengthening of local healthcare systems have also facilitated greater market penetration. With sustained global efforts to combat NTDs, the market for innovative and cost-effective treatment solutions is expected to expand, making significant progress toward eliminating these diseases.

SCOPE OF STUDY:

The report analyzes the Neglected Tropical Disease Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (NTD Drugs, NTD Vaccines); Disease Type (Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease, Chagas Disease, Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott Laboratories
• AbbVie Inc.
• Astellas Pharma Inc.
• AstraZeneca plc
• Bayer AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• Dr. Reddy's Laboratories Ltd.
• Eisai Co., Ltd.
• F. Hoffmann-La Roche Ltd
• Gilead Sciences, Inc.
• GlaxoSmithKline plc (GSK)
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Omega Diagnostics Group PLC
• Pfizer Inc.
• Sanofi
• Shionogi & Co., Ltd.
• Takeda Pharmaceutical Company Limited

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Neglected Tropical Disease Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Health Prioritization of NTDs Spurs Growth in Treatment Markets
  • WHO Roadmap for NTDs Strengthens Business Case for Scaled Investment in Therapies
  • Increased International Donor Funding Expands Addressable Market Opportunity for NTD Drugs
  • Advancements in Genomic and Molecular Research Drives Innovation in Targeted NTD Therapies
  • Integration of NTDs into Universal Health Coverage Plans Generates Long-Term Demand Potential
  • Cross-Sector Partnerships Between Governments, NGOs, and Pharma Accelerate Treatment Access
  • Growing Focus on One Health Approach Throws the Spotlight on Integrated Disease Management
  • Climate Change-Induced Spread of Vectors Expands Geographical Scope of NTD Markets
  • Enhanced Surveillance and Mapping Systems Drive Demand for Early-Stage Therapeutics
  • Public-Private Product Development Partnerships (PDPs) Sustain Growth in Clinical Pipelines
  • Regulatory Incentives and Priority Review Vouchers Propel Growth in R&D Investments
  • Emergence of Oral, Single-Dose Therapies Drives Adoption in Resource-Limited Settings
  • Innovations in Drug Formulations and Delivery Mechanisms Enhance Access and Patient Compliance
  • Digital Health and Remote Diagnostics Tools Generate Demand for Coordinated Care Solutions
  • Regional Disease Elimination Goals Throw the Spotlight on Scalable and Affordable Treatment Strategies
  • Technological Convergence with AI and Machine Learning Strengthens Business Case for Personalized NTD Interventions
  • Challenges in Supply Chain and Distribution Networks Create Bottlenecks to Market Penetration
  • Socioeconomic Burden of NTDs Drives Multilateral Commitments to Drug Availability
  • Greater Engagement from Emerging Market Pharmaceutical Companies Expands Treatment Accessibility
  • Rising Awareness Campaigns and Community Engagement Models Spur Uptake of NTD Medications
  • Policy-Driven Integration of NTD Care in Primary Healthcare Systems Generates Demand for Combination Therapies
  • Pressure to Develop Pediatric and Gender-Sensitive Formulations Drives Innovation in Inclusive Drug Design
  • Adoption of Open-Source Research Platforms Accelerates Development of Cost-Effective Treatments
  • Evolving Patent Expirations and Generic Drug Entry Opens Up Price-Competitive Market Landscape
  • Decentralization of Healthcare Services in Rural Regions Sustains Growth in Localized Treatment Models
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Neglected Tropical Disease Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Neglected Tropical Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for NTD Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for NTD Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for NTD Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for NTD Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for NTD Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for NTD Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Human African Trypanosomiasis Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Human African Trypanosomiasis Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Human African Trypanosomiasis Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Leishmaniases Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Leishmaniases Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Leishmaniases Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Soil-Transmitted Helminthiases Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Soil-Transmitted Helminthiases Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Soil-Transmitted Helminthiases Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Dengue Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Dengue Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Dengue Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Rabies Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Rabies Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Rabies Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Trachoma Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Trachoma Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Trachoma Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Buruli Ulcer Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Buruli Ulcer Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Buruli Ulcer Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Yaws Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Yaws Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Yaws Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Leprosy Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Leprosy Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Leprosy Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Chagas Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Chagas Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Chagas Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• JAPAN
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• CHINA
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• EUROPE
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Neglected Tropical Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• FRANCE
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• GERMANY
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 89: Italy Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Italy Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Italy 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Italy 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 95: UK Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: UK Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: UK 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 98: UK Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: UK Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: UK 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 101: Spain Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Spain Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Spain 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 104: Spain Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Spain Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Spain 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 107: Russia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Russia Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Russia 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 110: Russia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Russia Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Russia 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of Europe Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Rest of Europe Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Rest of Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 120: Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 128: Australia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Australia Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Australia 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 131: Australia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Australia Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Australia 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• INDIA
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 134: India Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: India Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: India 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 137: India Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: India Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: India 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 140: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: South Korea Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: South Korea 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 143: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: South Korea Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: South Korea 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 152: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Latin America Historic Review for Neglected Tropical Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 155: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Latin America Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 158: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Latin America Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 161: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Argentina Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Argentina 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 164: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Argentina Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Argentina 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 167: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Brazil Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Brazil 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 170: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Brazil Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Brazil 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 173: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Mexico Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Mexico 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 176: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Mexico Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Mexico 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Latin America Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Latin America Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 185: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Middle East Historic Review for Neglected Tropical Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 188: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Middle East Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 191: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Middle East Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 194: Iran Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Iran Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Iran 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 197: Iran Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Iran Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Iran 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 200: Israel Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Israel Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Israel 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 203: Israel Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Israel Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Israel 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Saudi Arabia Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Saudi Arabia 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Saudi Arabia Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Saudi Arabia 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 212: UAE Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: UAE Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: UAE 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 215: UAE Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: UAE Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: UAE 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Rest of Middle East Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Rest of Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Rest of Middle East Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Rest of Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
• AFRICA
  • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 224: Africa Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Africa Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Africa 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
  • TABLE 227: Africa Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Africa Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Africa 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030

IV. COMPETITION